Calcitriol in Preventing Lung Cancer in Smokers and Former Smokers at High Risk of Lung Cancer
Completed · Not applicable
Conditions studied: Lung Cancer, Precancerous Condition, Tobacco Use Disorder
In brief
RATIONALE: Calcitriol may prevent lung cancer in patients with metaplasia or dysplasia of the lungs. PURPOSE: This clinical trial is studying the side effects and best dose of calcitriol in preventing lung cancer in current smokers and former smokers at high risk of lung cancer.
Key facts
- Study ID
- NCT00690924
- Run by
- Roswell Park Cancer Institute
- People needed
- 16
- Starts
- 2008-07-17
- Expected to finish
- 2018-03-07
- Last updated by the study team
- 2018-06-04
Who can join
Age: 40 and older, up to 79. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Roswell Park Cancer Institute — Buffalo, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.